Commercialization News


GW Researcher Advances to the Final Round of NRG COSIA Carbon XPRIZE

April 09, 2018

A team of George Washington University researchers have been named as finalists in the $20 million

GW TCO's Commercialization Efforts Bring Research with ‘Broad Benefits’ to Market

March 07, 2018

GW TCO has successfully licensed GiaprezaTM (Angiotensin II) to La Joll

Pediatric Patient's Life Saved by GW Licensee, La Jolla Pharmaceutical's, Exerimental Drug

February 22, 2018

Pediatric patient's life is saved by GW licensee, La Jolla Pharmaceutical's, exerimental drug, GIAPREZA™.

NASA Launches PSLV-C40 Rocket with a Set of Micro Cathode Arc Thrusters Developed by GW Researcher, Michael Keidar

January 12, 2018

On January 11, the Indian Space Research Organization launched a PSLV-C40 rocket with a set of micro cathode arc thrusters onboard as part of its CANYVAL-X mission.  The thrusters were developed by

GW Professor, Mona Zaghoul, to be inducted in National Academy of Inventors

November 28, 2017

Mona Zaghloul, a School of Engineering and Applied Science professor who specializes in nanotechnologies, was nominated for outstanding contributions to innovation.


GW Startup News - La Jolla Pharmaceutical Company Announces U.S. FDA Acceptance of New Drug Application

August 28, 2017

La Jolla Pharmaceutical Company announced (on August 28, 2017) that the U.S.

GW Inventor, Mona Zaghloul, wins STTR Grant to Develop Photocathode Electron Sources with Muons, Inc.

June 26, 2017

Professor Mona Zaghloul (Electrical and Computer Engineering) is the principal investigator on a nine-month, $45,200 grant from the Department

GW Research Magazine highlights GW licensee's, Vector, Commercialization of GW's Plasma Thruster Technology.

June 01, 2017

Tiny thrusters created at GW soon could be powering the next generation of space exploration.

Lab to Launch

January 27, 2017

competition for stem entrepreneurs in Washington D.C through AAAS - read here.